Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Dishman Carbogen Amcis LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:540701NSE Symbol: DCALP/E(TTM):0
ISIN Demat:INE385W01011Div & Yield %:0EPS(TTM):0
Book Value(Rs):261.2390461Market Cap ( Cr.):3584.06Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 402.55306.61200.32580.74549.47474.46
Excise Duty0.000.000.000.000.000.00
Net Sales402.55306.61200.32580.74549.47474.46
Other Income 52.1660.3966.1569.5571.6865.66
Stock Adjustments -8.007.70-22.54-19.9634.8017.74
Total Income446.71374.70243.93630.33655.95557.86
EXPENDITURE :      
Raw Materials 163.35107.1175.04180.15197.38173.05
Power & Fuel Cost33.0724.8312.7835.2731.4428.48
Employee Cost 86.1379.0458.2388.8780.2761.67
Other Manufacturing Expenses 31.2122.5718.9526.5628.7119.26
Selling and Administration Expenses 52.5546.0328.9042.8448.6537.27
Miscellaneous Expenses 22.482.2143.2013.514.036.17
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure388.79281.79237.10387.20390.48325.90
Operating Profit57.9292.916.83243.13265.47231.96
Interest 57.9237.2334.1747.0247.4335.34
Gross Profit0.0055.68-27.34196.11218.04196.62
Depreciation96.20140.07141.35140.65136.31134.45
Profit Before Tax-96.20-84.39-168.6955.4681.7362.17
Tax0.000.0017.979.3017.017.52
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-37.33-52.8446.157.648.7117.58
Reported Net Profit-58.87-31.55-232.8138.5256.0137.07
Extraordinary Items -2.79-0.792.52-4.060.161.12
Adjusted Net Profit-56.08-30.76-235.3342.5855.8535.95
Adjst. below Net Profit 0.330.10-0.51-0.270.34-0.20
P & L Balance brought forward-175.91-144.4788.8553.83-2.53-39.39
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.003.230.000.00
P & L Balance carried down-234.45-175.92-144.4788.8553.82-2.52
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.0010.000.00
Earnings Per Share-Unit Curr-3.75-2.01-14.852.463.472.30
Earnings Per Share(Adj)-Unit Curr-3.75-2.01-14.852.463.472.30
Book Value-Unit Curr262.39269.88298.13305.66303.12296.88